Treatment of primary biliary cirrhosis

Bailliere's Best Practice and Research in Clinical Gastroenterology

Volumn 14, Issue 4, 2000, Pages 615-628

  Poupon, Raoul ^a   Poupon, Renée Eugénie ^b  

^a HÔPITAL SAINT ANTOINE   (France)

^b INSERM   (France)

Author keywords

Cholestasis; Fibrosis; Immunosuppression; Liver transplantation; Primary biliary cirrhosis; Ursodeoxycholic acid

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTIINFLAMMATORY AGENT; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; BILE ACID; BILIRUBIN; BUDESONIDE; COLCHICINE; COLESTYRAMINE; COPPER; CYCLOSPORIN; ESTROGEN; ETIDRONIC ACID; FLUORIDE SODIUM; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MITOCHONDRION ANTIBODY; NALMEFENE; NALOXONE; OPIATE ANTAGONIST; PENICILLAMINE; PHENOBARBITAL; PLACEBO; PREDNISOLONE; RIFAMPICIN; UNINDEXED DRUG; URSODEOXYCHOLIC ACID; VITAMIN D;

ARTICLE; AUTOIMMUNE HEPATITIS; CLINICAL FEATURE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DISEASE COURSE; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; HUMAN; HYPERBILIRUBINEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL PNEUMONIA; LIVER FIBROSIS; LIVER TOXICITY; LIVER TRANSPLANTATION; LONG TERM CARE; NEPHROTOXICITY; OSTEOPENIA; PRIMARY BILIARY CIRRHOSIS; PROGNOSIS; PRURITUS; STEATORRHEA; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT PLANNING; VITAMIN DEFICIENCY;

EID: 0033793443     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1053/bega.2000.0107     Document Type: Article

References (73)

1. Primary biliary cirrhosis
2. Serum bilirubin: A prognostic factor in primary biliary cirrhosis
3. Clinical pattern and course of disease in primary biliary cirrhosis based on an analysis of 236 patients
4. Non-suppurative destructive chronic cholangitis and chronic hepatitis
5. A prospective controlled trial of azathioprine in primary biliary cirrhosis
6. Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial
7. D-penicillamine treatment improves survival in primary biliary cirrhosis
8. A prospective trial of D-penicillamine in primary biliary cirrhosis
9. D-Penicillamine for primary biliary cirrhosis
10. Low therapeutic value of D-penicillamine in a short-term prospective trial in primary biliary cirrhosis
11. Double blind controlled trial of D-penicillamine in patients with primary biliary cirrhosis
12. A prospective clinical trial of D-penicillamine in the treatment of primary biliary cirrhosis
13. Trial of penicillamine in advanced primary biliary cirrhosis
14. A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results
15. A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis
16. Cyclosporin A treatment in primary biliary cirrhosis: Results of a long-term placebo controlled trial
17. A prospective trial of colchicine for primary biliary cirrhosis
18. A controlled trial of colchicine in primary biliary cirrhosis. Trial design and preliminary report
19. Evaluation of colchicine therapy in primary biliary cirrhosis
20. Primary biliary cirrhosis treated with low-dose oral pulse methotrexate
21. Low-dose of methotrexate is ineffective in primary biliary cirrhosis: Long-Term results of a placebo-controlled trial
22. Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: Effect of ursodeoxycholic acid
23. Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production
24. Ursodeoxycholic acid in cholestasis: Potential mechanisms of action and therapeutic applications
25. Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis
26. Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis
27. Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis
28. Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: Results of a double-blind controlled multicentric trial
29. A Markov model for assessment of histological progression in PBC provides evidence that UDCA therapy is effective in early stages
30. Clinical significance of serum bilirubin levels under ursodeoxycholic acid therapy in patients with primary biliary cirrhosis
31. Ursodeoxycholic acid delays the onset of esophageal varices in primary biliary cirrhosis
32. A randomized trial in primary biliary cirrhosis comparing ursodeoxycholic acid in daily doses of either 10 mg/kg or 20 mg/kg
33. Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: A randomized trial
34. Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: A meta-analysis
35. Ursodeoxycholic acid (UDCA) in primary biliary cirrhosis (PBC) - A Cochrane hepato-biliary systemic review
36. Ursodeoxycholic acid for primary biliary cirrhosis: Lessons from the past - Issues for the future
37. Discrepancies between meta-analyses and subsequent large randomized, controlled trials
38. Effects of ursodeoxycholic acid and ursodeoxycholic acid plus colchicine in primary biliary cirrhosis: A double-blind pilot study
39. Effects of additional administration of colchicine in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: A prospective randomized study
40. A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis
41. Positive responses to methotrexate and ursodeoxycholic acid in patients with primary biliary cirrhosis responding insufficiently to ursodeoxycholic acid alone
42. The combination of ursodeoxycholic acid and methotrexate for patients with primary biliary cirrhosis: The results of a pilot study
43. Combined treatment with methotrexate and ursodeoxycholic acid in non-cirrhotic primary biliary cirrhosis
44. The combination of ursodeoxycholic acid and methotrexate for primary biliary cirrhosis is not better than ursodeoxycholic acid alone
45. Methotrexate improves biochemical tests in patients with primary biliary cirrhosis who respond incompletely to ursodiol
46. Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis
47. Triple therapy with ursodeoxycholic acid, prednisone, and aziathioprine in primary biliary cirrhosis: A 1-year randomized, placebo-controlled study
48. Oral budesonide and ursodeoxycholic acid for treatment of primary biliary cirrhosis: Results of a prospective double-blind trial
49. Budesonide in the treatment of patients with primary biliary cirrhosis with suboptimal response to ursodeoxycholic acid
50. The pruritus of cholestasis
51. Pruritus in cholestasis: No direct cause for bile acid retention
52. Pruritus of cholestasis is related to effects of bile salts on the liver, not the skin
53. Opioid peptides and primary biliary cirrhosis
54. Comparison of rifampicin with phenobarbitone for treatment of pruritus in biliary cirrhosis
55. Effects of long-term rifampicin administration in primary biliary cirrhosis
56. Rifampin relieves pruritus in children with cholestatic liver disease
57. Treatment of pruritus in primary biliary cirrhosis with rifampin. Results of a double-blind, crossover, randomized trial
58. Effect of rifampicin in the treatment of pruritus in hepatic cholestasis
59. Effect of rifampicin treatment on hepatic drug metabolism and serum bile acids in patients with primary biliary cirrhosis
60. Treatment of pruritus of primary biliary cirrhosis with rifampin
61. Failure of rifampin to relieve pruritus in chronic liver disease
62. Naloxone modulates the perception of itch in man
63. Subhypnotic doses of propofol relieve pruritus associated with liver disease
64. Liver transplantation for primary biliary cirrhosis
65. Transplantation for primary biliary cirrhosis
66. Efficacy of liver transplantation in patients with primary biliary cirrhosis
67. Hepatic osteodystrophy in primary biliary cirrhosis: Effects of medical treatment
68. Transplantation in primary biliary cirrhosis
69. Histological evidence for recurrence of primary biliary cirrhosis after liver transplantation
70. Is there recurrence of primary biliary cirrhosis after liver transplantation? A clinicopathologic study in long-term survivors
71. Evidence for disease recurrence after liver transplantation for primary biliary cirrhosis
72. Primary biliary cirrhosis. Histologic evidence of disease recurrence after liver transplantation
73. Development Conference Statement: Liver transplantation - June 20-23, 1983